Operating

Noncash Lease Income Expense

Kailera Therapeutics Noncash Lease Income Expense decreased by 2353.8% to -$293.00K in Q1 2026 compared to the prior quarter.

Analysis

StatementCash Flow Statement
SectionOperating
First reportedQ1 2025
Last reportedQ1 2026May 26, 2026
Metric ID: operating_noncash_lease_income_expense

Historical Data

2 periods
 Q1 '25Q1 '26
Value$13.00K-$293.00K
QoQ Change—<-999%
YoY Change—<-999%
Range-$293.00K – $13.00K
Avg YoY Growth<-999%
Median YoY Growth<-999%

Frequently Asked Questions

What is Kailera Therapeutics 's noncash lease income expense?
Kailera Therapeutics (KLRA) reported noncash lease income expense of -$293.00K in Q1 2026.